10th Life Science Symposium

Tobias Gantner is no ordinary speaker - he is someone who burns with every fiber for a new, better healthcare system. A system that no longer waits for approvals, but acts. That puts people at the center. And that sees technology not as an end in itself, but as a tool for greater justice and quality of life.

Trained in medicine, law, philosophy and health economics, he made a conscious decision against traditional careers - and founded HealthCare Futurists instead. Not a company, but an attitude. A place where new ideas are allowed to emerge. And implemented.

Tobias doesn't build castles in the air. He builds real solutions: mobile clinics without doctors, pharmacies of the future made from Lego, AI tools for care, playful approaches to prevention and hackathons that become drivers of real change. The World Health Organization (WHO) ranks him among the 50 most important experts in digital health worldwide. The press calls him the "Q of medicine".

What drives him? The conviction that health needs to be rethought - and that we can do it together. That curiosity is the most important superpower. And that we can question the rules to make them better.

You can look forward to a lecture that moves. That gives you courage. That shows what is possible if you don't ask whether you can - but whether it makes sense.

Dr. Klaus Suwelack is a seasoned leader in pharmaceutical innovation. With over two decades of experience, he has been pivotal in building integrated clinical ecosystems that connect end-to-end process chains with cross-functional collaboration at companies like Janssen and J&J, all powered by modern technology. He played a central role in initiatives like “The New Health Care Innovation Puzzle,” which brings together partners across sectors to develop patient-centered solutions. Additionally, he supports biotech and digital health startups, helping them navigate early-stage development and clinical entry. Dr. Suwelack’s work continues to shape the future of pharmaceutical R&D through seamless integration and innovation.

COO, Connected Discovery a consultancy-based SME, Bryn also has wide experience of working with large pharma, public initiatives, and SMEs, with a particular emphasis on exploratory new idea generation, target validation and progression, and the application of data and knowledge to early drug discovery.
Previously, Bryn was SVP Drug Discovery at Benevolent AI leading early drug research. This involved fast moving data science and applied AI in combination with a focus on drug target ideation, validation, and progression to a fast-moving diverse drug programme portfolio.

Prior to this, Bryn led the Open PHACTS Innovative Medicine Initiative project and is the CEO of the Open PHACTS Foundation, which together are pioneering the development of semantic web technologies to the open integration of interoperable bioscience-relevant data. With an emphasis on early discovery-relevant data, Open PHACTS blazed the trail for the FAIR data ecosystem rapidly spreading across biomedical data practice. Before this, Bryn was at Pfizer for nearly 20 years in a variety of research and bioinformatics roles.
 

Peter Soelkner is CEO / Managing Director of Vetter Pharma, a global leader in aseptic filling and packaging of injectable drugs. Over his 17-year executive tenure, including leadership as of May 2025, he has driven a tenfold revenue increase and expanded Vetter’s international presence, with a strong focus on the U.S. market. His leadership has positioned Vetter as a trusted partner in complex injectables and sterile drug delivery.

Having spent 19 years in the U.S., Peter brings deep expertise in international biopharma partnerships. Beyond Vetter, he holds key non-executive roles: Vice Chair at Oxford Biomedica, Non-Executive Director at Coriolis Pharma, and Operating Partner at Advent International. Across these roles, he bridges science, operations, investment, and regulation—offering a global perspective on healthcare transformation and U.S. market dynamics.

Andreas Axmann is a digital entertainer and as such has won several international awards. It all started in the classic way: with the obligatory magic box for Christmas, which an aunt gave him. Further support came from the German magic club "Magischer Zirkel", which accepted him in 2002. So it was obvious that he would soon be presenting his skills in public. Andreas Axmann came to Berlin in 2004 to begin his studies in theater and event technology, which he completed in 2008 with a diploma thesis on the subject of "magic theater". Since then, magic has been his main profession. In 2010, Andreas Axmann became the first German iPad magician to specialize in the field of "digital magic". In 2011, the media magician became German runner-up in the "magic with presentation" category. He was also engaged for the first time this year with his iPad magic in Las Vegas. In 2022, Andreas Axmann has been on stage for 30 years and has made the digital topic of "human-machine interaction" his specialty. Recently, he has increasingly devoted himself to artificial intelligence and the metaverse.

Christoph Kuch inspires audiences around the world with his mental magic and amazing illusions. Born in Nuremberg, he is a world champion magician in the field of mental magic and has also impressed audiences in the US show "Penn & Teller: Fool Us". His shows take him through Europe, Asia, Australia and the USA.

Fascinated by magic since childhood, he became German Champion in 2011 and won the World Championships in Blackpool in 2012. This was followed by performances at the legendary Magic Castle in Los Angeles.

With humor, charm and excitement, he inspires in his shows "Ich weiß." and "Macht verrückt" as well as at events and galas. As a speaker, he talks about perception and self-deception. He is also the author of the bestseller "Don't be superstitious, it's bad luck!" and has appeared in numerous TV shows.

Photo: Jean Ferry

Dr. Sven Jungmann is a doctor, innovation expert and founder of a medical AI start-up. In addition to and after his clinical work in pneumology and the emergency department at Helios and Charité, he has been dedicated to the digital transformation of the healthcare sector for over 10 years. He has advised companies such as Audi, Gothaer, Roche and a Kuwaiti pharmacy chain on digital healthcare innovation. Handelsblatt listed him among Germany's 100 brightest minds back in 2017. In 2022, he won the EUR 25,000 Digital Health Award for an innovation in the field of AI-driven diagnostics. Jungmann is also an investor himself and sits on the medical advisory board of venture capitalist SpeedInvest. He also enjoys writing on the subject of healthcare innovation, for example in his book published by Penguin RandomHouse or in a thesis paper on "Shared Decision Making in the Age of AI" published with Roche's Independent Patient Council. In addition to medicine, he also studied public health at LSHTM, public policy at Oxford and entrepreneurship at Cambridge.

Photo: Frank Nürnberger

Frank Dullweber is an experienced life science professional. Due to his long-term experience in pharmaceutical research, he has an in-depth understanding of data domains relevant to pre-clinical and clinical drug discovery and clinical development. He graduated with a PhD in cheminformatics and obtained a master's degree in clinical research management. Until recently, he worked in bioinformatics and is now a member of the Center of Excellence for Digital Transformation in the clinical development domain.

Dr. Felix Lenk studied automation and control engineering at the Technical University of Dresden, where he also completed his doctorate and established and headed the SmartLab Systems research group. He is the founder and Managing Director of SmartLab Solutions GmbH and amensio GmbH - two high-tech start-ups for laboratory digitization.

He works as an honorary expert and consultant for the Federal Ministry of Research, Technology and Space, the industry association Spectaris e.V. and the Society for Laboratory Automation and Screening (SLAS).

Oliver is an experienced project manager and consultant with 13 years of experience in the life sciences sector. He specializes in the implementation and integration of various systems, including quality management systems (QMS), electronic data capture (EDC) and regulatory information management (RIM). As a generalist with a technical background, Oliver has developed a comprehensive understanding of processes, business areas and systems that allows him to take a holistic perspective. His diverse client portfolio includes pharmaceutical companies, biotechnology companies, medical device manufacturers and regulatory authorities.